Structural insights into recognition of β2-glycoprotein I by the lipoprotein receptors
Dmitri Beglov
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorChang-Jin Lee
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
Search for more papers by this authorAlfredo De Biasio
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
Search for more papers by this authorDima Kozakov
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorRyan Brenke
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorSandor Vajda
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorCorresponding Author
Natalia Beglova
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave, Boston, MA 02215===Search for more papers by this authorDmitri Beglov
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorChang-Jin Lee
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
Search for more papers by this authorAlfredo De Biasio
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
Search for more papers by this authorDima Kozakov
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorRyan Brenke
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorSandor Vajda
Department of Biomedical Engineering, Boston University, Boston, Massachusetts 02215
Search for more papers by this authorCorresponding Author
Natalia Beglova
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215
Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Ave, Boston, MA 02215===Search for more papers by this authorAbstract
The interactions of β2 glycoprotein I (B2GPI) with the receptors of the low-density lipoprotein receptor (LDLR) family are implicated in the clearance of negatively charged phospholipids and apoptotic cells and, in the presence of autoimmune anti-B2GPI antibodies, in cell activation, which might play a role in the pathology of antiphospholipid syndrome (APS). The ligand-binding domains of the lipoprotein receptors consist of multiple homologous LA modules connected by flexible linkers. In this study, we investigated at the atomic level the features of the LA modules required for binding to B2GPI. To compare the binding interface in B2GPI/LA complex to that observed in the high-resolution co-crystal structure of the receptor associated protein (RAP) with a pair of LA modules 3 and 4 from the LDLR, we used LA4 in our studies. Using solution NMR spectroscopy, we found that LA4 interacts with B2GPI and the binding site for B2GPI on the 15N-labeled LA4 is formed by the calcium coordinating residues of the LA module. We built a model for the complex between domain V of B2GPI (B2GPI-DV) and LA4 without introducing any experimentally derived constraints into the docking procedure. Our model, which is in the agreement with the NMR data, suggests that the binding interface of B2GPI for the lipoprotein receptors is centered at three lysine residues of B2GPI-DV, Lys 308, Lys 282, and Lys317. Proteins 2009. © 2009 Wiley-Liss, Inc.
REFERENCES
- 1 Lin F,Murphy R,White B,Kelly J,Feighery C,Doyle R,Pittock S,Moroney J,Smith O,Livingstone W,Keenan C,Jackson J. Circulating levels of beta2-glycoprotein I in thrombotic disorders and in inflammation. Lupus 2006; 15: 87–93.
- 2 Moestrup SK,Schousboe I,Jacobsen C,Leheste JR,Christensen EI,Willnow TE. Beta2-glycoprotein-I (apolipoprotein H) and beta2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. J Clin Invest 1998; 102: 902–909.
- 3 Lutters BC,Derksen RH,Tekelenburg WL,Lenting PJ,Arnout J,de Groot PG. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J Biol Chem 2003; 278: 33831–33838.
- 4 Maiti SN,Balasubramanian K,Ramoth JA,Schroit AJ. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem 2008; 283: 3761–3766.
- 5 Pennings MT,Derksen RH,Urbanus RT,Tekelenburg WL,Hemrika W,de Groot PG. Platelets express three different splice variants of ApoER2 that are all involved in signaling. J Thromb Haemost 2007; 5: 1538–1544.
- 6 Pennings MT,Derksen RH,van Lummel M,Adelmeijer J,VanHoorelbeke K,Urbanus RT,Lisman T,de Groot PG. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2′. J Thromb Haemost 2007; 5: 369–377.
- 7 Urbanus RT,Pennings MT,Derksen RH,de Groot PG. Platelet activation by dimeric beta(2)-glycoprotein I requires signaling via both glycoprotein Ibalpha and apolipoprotein E receptor 2′. J Thromb Haemost 2008; 6: 1405–1412.
- 8 van Lummel M,Pennings MT,Derksen RH,Urbanus RT,Lutters BC,Kaldenhoven N,de Groot PG. The binding site in β2-glycoprotein I for ApoER2′ on platelets is located in domain V. J Biol Chem 2005; 280: 36729–36736.
- 9 Miyakis S,Lockshin MD,Atsumi T,Branch DW,Brey RL,Cervera R,Derksen RH,de Groot PG,Koike T,Meroni PL,Reber G,Shoenfeld Y,Tincani A,Vlachoyiannopoulos PG,Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295–306.
- 10 Salmon JE,de Groot PG. Pathogenic role of antiphospholipid antibodies. Lupus 2008; 17: 405–411.
- 11 Giannakopoulos B,Passam F,Rahgozar S,Krilis SA. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 2007; 109: 422–430.
- 12 Urbanus RT,Derksen RH,de Groot PG. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev 2008; 22: 93–105.
- 13 May P,Herz J,Bock HH. Molecular mechanisms of lipoprotein receptor signalling. Cell Mol Life Sci 2005; 62: 2325–2338.
- 14 Jeon H,Blacklow SC. Structure and physiologic function of the low-density lipoprotein receptor. Annu Rev Biochem 2005; 74: 535–562.
- 15 Pennings MT,van Lummel M,Derksen RH,Urbanus RT,Romijn RA,Lenting PJ,de Groot PG. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. JThromb Haemost 2006; 4: 1680–1690.
- 16 Meroni PL,Ronda N,De Angelis V,Grossi C,Raschi E,Borghi MO. Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: in vitro and in vivo studies. Clin Rev Allergy Immunol 2007; 32: 67–74.
- 17 Herz J,Bock HH. Lipoprotein receptors in the nervous system. Annu Rev Biochem 2002; 71: 405–434.
- 18 Blacklow SC,Kim PS. Protein folding and calcium binding defects arising from familial hypercholesterolemia mutations of the LDL receptor. Nat Struct Biol 1996; 3: 758–762.
- 19 Fass D,Blacklow S,Kim PS,Berger JM. Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 1997; 388: 691–693.
- 20 Beglova N,Jeon H,Fisher C,Blacklow SC. Cooperation between fixed and low pH-inducible interfaces controls lipoprotein release by the LDL receptor. Mol Cell 2004; 16: 281–292.
- 21 Daly NL,Djordjevic JT,Kroon PA,Smith R. Three-dimensional structure of the second cysteine-rich repeat from the human low-density lipoprotein receptor. Biochemistry 1995; 34: 14474–14481.
- 22 Daly NL,Scanlon MJ,Djordjevic JT,Kroon PA,Smith R. Three-dimensional structure of a cysteine-rich repeat from the low-density lipoprotein receptor. Proc Natl Acad Sci USA 1995; 92: 6334–6338.
- 23 Dolmer K,Huang W,Gettins PG. NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein. Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin. J Biol Chem 2000; 275: 3264–3269.
- 24 Fisher C,Beglova N,Blacklow SC. Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol Cell 2006; 22: 277–283.
- 25 Huang W,Dolmer K,Liao X,Gettins PG. NMR solution structure of the receptor binding domain of human alpha(2)-macroglobulin. J Biol Chem 2000; 275: 1089–1094.
- 26 Jensen GA,Andersen OM,Bonvin AM,Bjerrum-Bohr I,Etzerodt M,Thogersen HC,O'Shea C,Poulsen FM,Kragelund BB. Binding site structure of one LRP-RAP complex: implications for a common ligand-receptor binding motif. J Mol Biol 2006; 362: 700–716.
- 27 North CL,Blacklow SC. Solution structure of the sixth LDL-A module of the LDL receptor. Biochemistry 2000; 39: 2564–2571.
- 28 Querol-Audi J,Konecsni T,Pous J,Carugo O,Fita I,Verdaguer N,Blaas D. Minor group human rhinovirus-receptor interactions: geometry of multimodular attachment and basis of recognition. FEBS Lett 2009; 583: 235–240.
- 29 Rudenko G,Henry L,Henderson K,Ichtchenko K,Brown MS,Goldstein JL,Deisenhofer J. Structure of the LDL receptor extracellular domain at endosomal pH. Science 2002; 298: 2353–2358.
- 30 Simonovic M,Dolmer K,Huang W,Strickland DK,Volz K,Gettins PG. Calcium coordination and pH dependence of the calcium affinity of ligand-binding repeat CR7 from the LRP. Comparison with related domains from the LRP and the LDL receptor. Biochemistry 2001; 40: 15127–15134.
- 31 Verdaguer N,Fita I,Reithmayer M,Moser R,Blaas D. X-ray structure of a minor group human rhinovirus bound to a fragment of its cellular receptor protein. Nat Struct Mol Biol 2004; 11: 429–434.
- 32 Wolf CA,Dancea F,Shi M,Bade-Noskova V,Ruterjans H,Kerjaschki D,Lucke C. Solution structure of the twelfth cysteine-rich ligand-binding repeat in rat megalin. J Biomol NMR 2007; 37: 321–328.
- 33 Bouma B,de Groot PG,van den Elsen JM,Ravelli RB,Schouten A,Simmelink MJ,Derksen RH,Kroon J,Gros P. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. Embo J 1999; 18: 5166–5174.
- 34 Schwarzenbacher R,Zeth K,Diederichs K,Gries A,Kostner GM,Laggner P,Prassl R. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. Embo J 1999; 18: 6228–6239.
- 35 Pons J-L,Malliavin TE,Delsuc MA.Gifa V. A complete package for NMR data set processing. J Biomol NMR 1996; 8: 445–452.
- 36 Wishart DS,Bigam CG,Yao J,Abildgaard F,Dyson HJ,Oldfield E,Markley JL,Sykes BD. 1H, 13C and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 1995; 6: 135–140.
- 37 Kozakov D,Brenke R,Comeau SR,Vajda S. PIPER: an FFT-based protein docking program with pairwise potentials. Proteins 2006; 65: 392–406.
- 38 Comeau SR,Kozakov D,Brenke R,Shen Y,Beglov D,Vajda S. ClusPro: performance in CAPRI rounds 6–11 and the new server. Proteins 2007; 69: 781–785.
- 39 Shen Y,Brenke R,Kozakov D,Comeau SR,Beglov D,Vajda S. Docking with PIPER and refinement with SDU in rounds 6–11 of CAPRI. Proteins 2007; 69: 734–742.
- 40 Brooks BR,Bruccoleri RE,Olafson BD,States DJ,Swaminathan S,Karplus M. CRARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 1983; 4: 187–217.
- 41 DeLano WL. The PyMOL molecular graphics system. Palo Alto, CA: DeLano Scientific; 2002.
- 42 Collaborative Computational Project. The CCP4 suite: programs for protein crystallography; 1994.
- 43 Beglova N,North CL,Blacklow SC. Backbone dynamics of a module pair from the ligand-binding domain of the LDL receptor. Biochemistry 2001; 40: 2808–2815.
- 44 Shortridge MD,Hage DS,Harbison GS,Powers R. Estimating protein-ligand binding affinity using high-throughput screening by NMR. J Comb Chem 2008; 10: 948–958.
- 45 Mehdi H,Naqvi A,Kamboh MI. A hydrophobic sequence at position 313–316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding. Eur J Biochem 2000; 267: 1770–1776.
- 46 Sheng Y,Sali A,Herzog H,Lahnstein J,Krilis SA. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J Immunol 1996; 157: 3744–3751.
- 47 Andersen OM,Christensen PA,Christensen LL,Jacobsen C,Moestrup SK,Etzerodt M,Thogersen HC. Specific binding of alpha-macroglobulin to complement-type repeat CR4 of the low-density lipoprotein receptor-related protein. Biochemistry 2000; 39: 10627–10633.
- 48 Andersen OM,Schwarz FP,Eisenstein E,Jacobsen C,Moestrup SK,Etzerodt M,Thogersen HC. Dominant thermodynamic role of the third independent receptor binding site in the receptor-associated protein RAP. Biochemistry 2001; 40: 15408–15417.
- 49 Estrada K,Fisher C,Blacklow SC. Unfolding of the RAP-D3 helical bundle facilitates dissociation of RAP-receptor complexes. Biochemistry 2008; 47: 1532–1539.
- 50 Andersen OM,Benhayon D,Curran T,Willnow TE. Differential binding of ligands to the apolipoprotein E receptor 2. Biochemistry 2003; 42: 9355–9364.
- 51 Andersen OM,Christensen LL,Christensen PA,Sorensen ES,Jacobsen C,Moestrup SK,Etzerodt M,Thogersen HC. Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP). A conserved acidic residue in the complement-type repeats is important for recognition of RAP. J Biol Chem 2000; 275: 21017–21024.
- 52 Fisher C,Abdul-Aziz D,Blacklow SC. A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands. Biochemistry 2004; 43: 1037–1044.